Access full Research:
Get Free Customization in this Report
United States is the hub of proton therapy industry where various advanced and children specialist centers and preferential facilities are available for the child. In United States, currently 31 proton therapy centers are operational, and many centers are in the constructional phase and planning phase. Proton therapy centers are growing at a rapid pace in United States as its cancer incidences are raising and there are more patients eligible for treatment than actually resources available for them. Proton therapy is one of the advanced techniques of radiotherapy which produces optimal amount of radiation or pinpoint radiation to kill tumor and mitigate radiation exposure to healthy tissues or cells. The potential of United States Proton Therapy Market is expected to be more than USD 16 Billion by the end of year 2025. But the actual market is merely 10% of the potential market due to demand-supply mismatch.
Proton therapy is a non-invasive procedure that is used for the treatment of multiple cancers like CNS Cancer, Head & Neck Cancer, Prostate Cancer, Breast Cancer and Lung Cancer etc. People across the world are looking for the non-invasive procedure because of its effectiveness and painless outcome. The clinical benefit of using proton therapy is its minimal side effects because proton therapy affects less radiation to healthy tissues or cells.
Besides, proton therapy can be an effective treatment for recurrent tumors. Proton therapy is one of the effective treatments for pediatric patients rather than conventional radiotherapy and surgery that include various risks and complications. Additionally, children body is prone to the re-occurrence of cancer and proton therapy plays an essential role by preventing from re-occurrence. The survival rate of proton therapy is nearly 90 percent which is far better than the traditional technique to treat cancer.
“United States Proton Therapy Market, Patient Numbers by 14 Types of Cancer, Reimbursement Policy, Patients Treated at Proton Therapy Centers” is a report published by Renub Research. In this report, we have studied the market in two parts a) Actual Market and b) Potential Market. The report also talks about the list of all operational and Proton Therapy centers going to open in future; Economics of proton therapy including reimbursement policies. Proton Therapy revenues from 3 companies (IBA, Varian Medical Systems, Elekta) has also been studied in the report.
- Actual Market is the current market which is already present
- Potential Market is the market which can be achieved; but it has yet not been achieved due to demand and supply gap. At present only a few proton therapy centers are available that can treat a limited number of patients each year
Patient Numbers for the Treatment of Proton Therapy in United States
In this report, we have portrayed proton therapy patients into two parts; potential patients and actual one. We have also categorized the proton therapy patient numbers on the basis of cancer type into 14 sections; Central Nervous System Tumors, Intraocular Melanomas, Pituitary Neoplasms, Base of Skull / Axial Skeleton, Head and Neck, Lung Cancers, Retroperitoneal Sarcoma, Pediatric (Up to Age 18), Gastrointestinal Tract, Urinary Tract, Female Pelvic Organs, Prostate Cancer, Breast Cancer and Other.
Proton Therapy Market for 14 Types of Cancer in United States
The proton therapy market is divided into two parts; potential proton therapy market and actual proton therapy market. This report studies the 14 cancer types proton therapy market Retroperitoneal Sarcoma, Central Nervous System Tumors, Pituitary Neoplasms, Intraocular Melanomas, Lung Cancers, Base of Skull / Axial Skeleton, Gastrointestinal Tract, Pediatric (Up to Age 18), Urinary Tract, Head and Neck, Breast Cancer, Female Pelvic Organs, Prostate Cancer, and Other.
According to Renub Research Analysis, the more patients of cancer would get proton therapy treatment in United States due to rising prevalence of cancer and an increasing number of the advanced proton therapy center. Additionally, increasing technological development in Proton therapy and increasing efficiencies will further boost the market of proton therapy in United States.
Number of Patients Treated in each Proton Therapy Center of United States
In this report, we have done a full assessment of proton therapy center of United States with their treatment capabilities and technology used. Currently, there are 31 operational centers for proton therapy in United States, and XX centers are in construction phase and XX are in planning phase. In this report we have provided complete patients number treated with proton therapy by each proton therapy center of United States.
Reimbursement Policy Insights
Here, we have done an in-depth analysis of reimbursement policies in United States. Here, we have fragmented the reimbursement policy into two parts; the first one is by patient’s perspective, and the second one is by manufacturer, stakeholder and institutional perspective.
Key Companies Covered
- IBA (Overview, Sales Analysis)
- Varian Medical Systems (Overview, Sales Analysis)
- Elekta (Overview, Sales Analysis)
United States Proton Therapy Market & Patient Numbers has been analyzed from two viewpoints
- Actual & Potential Market
- Actual & Potential Number of Patients Treated
14 Types of Cancer - Patient Numbers & Market
- Central Nervous System Tumors Cancer
- Pituitary Neoplasms Cancer
- Intraocular Melanomas Cancer
- Lung Cancers
- Base of Skull / Axial Skeleton Cancer
- Gastrointestinal Tract Cancer
- Pediatric (Up to Age 18) Cancer
- Urinary Tract Cancer
- Head and Neck Cancer
- Breast Cancer
- Female Pelvic Organs Cancer
- Prostate Cancer
- Retroperitoneal Sarcoma Cancer
- Other Cancer
If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team email@example.com
Renub Research is a leading Market Research and Information Analysis Company with centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others.
Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in today’s ultra-competitive markets.